ロード中...
CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders
Astrocytic impairment is a pathologic feature of neuromyelitis optica spectrum disorder (NMOSD). S100B and glial fibrillary acidic protein (GFAP) are the two most commonly used astrocytic markers. The aim of this study was to evaluate whether CSF-S100B could serve as a marker of NMOSD. We enrolled 4...
保存先:
| 出版年: | Biomed Res Int |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217894/ https://ncbi.nlm.nih.gov/pubmed/30426010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5381239 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|